Attitudes Toward Diabetes Affect Maintenance of Drug-Free Remission in Patients With Newly Diagnosed Type 2 Diabetes After Short-Term Continuous Subcutaneous Insulin Infusion Treatment

Ailing Chen; Zhimin Huang; Xuesi Wan; Wanping Deng; Jiyan Wu; Licheng Li; Qiuling Cai; Haipeng Xiao; Yanbing Li
March 2012
Diabetes Care;Mar2012, Vol. 35 Issue 3, p474
Academic Journal
OBJECTIVE--Short-term intensive insulin treatment in patients with newly diagnosed type 2 diabetes can improve β-cell function and insulin sensitivity, which results in long-term remission without need for further antidiabetes medication. Patient attitudes toward their disease were assessed using the Diabetes Care Profile (DCP) tool to evaluate the potential impact on maintaining long-term remission. RESEARCH DESIGN AND METHODS--Newly diagnosed patients with type 2 diabetes were recruited and treated with continuous subcutaneous insulin infusion (CSII) for 2-3 weeks. They were also invited to participate in diabetes self-management intervention during hospitalization and complete a DCP questionnaire on attitudes toward diabetes at baseline and 3, 6, and 12 months after suspension of CSII. RESULTS--Near normoglycemia was achieved by 118 patients after short-term CSII, with 65 remaining in drug-free remission for >1 year. They had significantly better glycemic control and greater restoration of acute insulin response after CSII as well as higher educational attainment compared with patients experiencing relapse. They also achieved higher scores in positive attitude, (belief in) importance of care, care ability, self-care adherence, and less negative attitude. Differences between the two groups became greater over time. Cox proportional hazards model analysis indicated that greater self-care adherence (hazard ratio 0.184, P < 0.001) and homeostasis model assessment of insulin resistance before treatment (0.854, P = 0.053) were independent predictors for long-term remission, whereas elevated 2-h postprandial plasma glucose after CSII (1.156, P = 0.015) was a risk factor for relapse. CONCLUSIONS--Attitudes toward diabetes affect long-term drug-free remission in newly diagnosed patients with type 2 diabetes after short-term CSII.


Related Articles

  • Phloridzin improves hyperglycemia but not hepatic insulin resistance in a transgenic mouse model of type 2 diabetes. Zhao, Hong; Yakar, Shoshana; Gavrilova, Oksana; Sun, Hui; Zhang, Yang; Kim, Hyunsook; Setser, Jennifer; Jou, William; LeRoith, Derek // Diabetes;Nov2004, Vol. 53 Issue 11, p2901 

    The chronic hyperglycemia that occurs in type 2 diabetes may cause deterioration of beta-cell function and insulin resistance in peripheral tissues. Mice that express a dominant-negative IGF-1 receptor, specifically in skeletal muscle (MKR mice), exhibit severe insulin resistance,...

  • Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance. Ehrmann, D. A.; Breda, E.; Cavaghan, M. K.; Bajramovic, S.; Imperial, J.; Toffolo, G.; Cobelli, C.; Polonsky, K. S. // Diabetologia;Apr2002, Vol. 45 Issue 4, p509 

    Aims/hypothesis. We hypothesized that beta-cell responses to changes in glucose would not be normal in subjects with impaired glucose tolerance (IGT). Methods. Three groups of 6 subjects were studied: normal weight with normal glucose tolerance (control subjects); obese with normal glucose...

  • Predicting the development of diabetes.  // Clinical Oncology Alert;Sep2009 Supplement, p17 

    This article deals with a study that examined trends in markers of glucose dysregulation in people without diabetes. British civil servants served as subjects in this study. 505 subjects developed diabetes at a median of 9.7 years follow-up. Results of the study showed that subjects who...

  • Beta cell dysfunction and insulin resistance. Cerf, Marlon E. // Frontiers in Endocrinology;Mar2013, Vol. 4, p1 

    Beta cell dysfunction and insulin resistance are inherently complex with their interrelation for triggering the pathogenesis of diabetes also somewhat undefined. Both pathogenic states induce hyperglycemia and therefore increase insulin demand. Beta cell dysfunction results from inadequate...

  • Plasma Fetuin-A Levels and the Risk of Type 2 Diabetes. Stefan, Norbert; Fritsche, Andreas; Weikert, Cornelia; Boeing, Heiner; Joost, Hans-Georg; Håring, Hans-Ulrich; Schulze, Matthias B. // Diabetes;Oct2008, Vol. 57 Issue 10, p2762 

    OBJECTIVE--The liver-secreted protein fetuin-A induces insulin resistance in animals, and circulating fetuin-A is elevated in insulin resistance and fatty liver in humans. We investigated whether plasma fetuin-A levels predict the incidence of type 2 diabetes in a large prospective,...

  • The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β-cell mass: implications in the development of type-2 diabetes. Xie, Jianling; Herbert, Terence // Cellular & Molecular Life Sciences;Apr2012, Vol. 69 Issue 8, p1289 

    Type-2 diabetes mellitus (T2DM) is a disorder that is characterized by high blood glucose concentration in the context of insulin resistance and/or relative insulin deficiency. It causes metabolic changes that lead to the damage and functional impairment of organs and tissues resulting in...

  • β-Cell Function in Obesity. Ferrannini, Ele; Camastra, Stefania; Gastaldelli, Amalia; Sironi, Anna Maria; Natali, Andrea; Muscelli, Elza; Mingrone, Geltrude; Mari, Andrea // Diabetes;Dec2004 Supplement, Vol. 53, pS26 

    In nondiabetic subjects, obesity is associated with a modest expansion of β-cell mass, possibly amounting--according to the best available estimates--to 10-30% for each 10 kg of weight excess. Whether age of onset and duration of obesity, recent changes in body weight, and body fat...

  • Problems associated with glucose toxicity: Role of hyperglycemia-induced oxidative stress. Kawahito, Shinji; Kitahata, Hiroshi; Oshita, Shuzo; Buechler, Christa // World Journal of Gastroenterology;9/7/2009, Vol. 15 Issue 33, p4137 

    Glucose homeostasis deficiency leads to a chronic increase in blood glucose concentration. In contrast to physiological glucose concentration, chronic super-physiological glucose concentration negatively affects a large number of organs and tissues. Glucose toxicity means a decrease in insulin...

  • Insulin hormone: Mechanism and effects on the body and relationship with central nervous system. Ünal, Deniz; Kara, Adem; Aksak, Selina; Zuhal Altunkaynak, B.; Yıldırım, Serap // Dicle Medical Journal / Dicle Tip Dergisi;2012, Vol. 39 Issue 2, p310 

    Diabetes mellitus (DM) is one of the most common and chronic disease all over the world. It is characterized with either insulin deficiency or insulin resistance. Insulin is a hormone which is secreted by beta cells in the Langerhans Islets of pancreas and playing a role in carbohydrate...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics